GSK launches Sensimist and reports 2% growth

13 February 2017 - Deborah Wilkes

Archived

GlaxoSmithKline has launched Flonase Sensimist Allergy Relief in the US, as it reported a 2% rise in worldwide sales at its Consumer Healthcare business in the fourth quarter of 2016.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: